Benchmark Downgrades Bio-Techne to Hold

Benzinga Newsdesk www.benzinga.com Negative 93.2%

Neg 93.2% Neu 0% Pos 0%

Benchmark analyst Robert Wasserman downgrades Bio-Techne (NASDAQ:TECH) from Buy to Hold.

Comments

No comments yet. Be the first!